Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide

The Sphingosine-1-Phosphate Receptor S1PR1 Restricts Sprouting Angiogenesis by Regulating the Interplay between VE-Cadherin and VEGFR2

(2012) Konstantin Gaengel et al.   DEVELOPMENTAL CELL

Coupling In vitro and In vivo Paradigm Reveals a Dose Dependent Inhibition of Angiogenesis Followed by Initiation of Autophagy by C6-Ceramide

(2012) Rishipal R. Bansode et al.   International Journal of Biological Sciences

Beta-Glucosylceramide Administration (i.p.) Activates Natural Killer T cells In Vivo and Prevents Tumor Metastasis in Mice

(2012) Masashi Inafuku et al.   LIPIDS

Orally Administered Glucosylceramide Improves the Skin Barrier Function by Upregulating Genes Associated with the Tight Junction and Cornified Envelope Formation

(2011) Ritsuro IDETA et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance

(2011) Brian M. Barth et al.   CANCER BIOLOGY & THERAPY

Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice

(2010) Kazunori Fujiwara et al.   International Journal of Clinical Oncology

Intestinal absorption of dietary maize glucosylceramide in lymphatic duct cannulated rats

(2010) Tatsuya Sugawara et al.   JOURNAL OF LIPID RESEARCH

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

(2009) Axel Grothey et al.   Nature Reviews Clinical Oncology

The sphingolipid salvage pathway in ceramide metabolism and signaling

(2008) Kazuyuki Kitatani et al.   CELLULAR SIGNALLING

Principles of bioactive lipid signalling: lessons from sphingolipids

(2008) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY